Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Association of plasminogen activator inhibitor type 2 (PAI-2) with proteasome within endothelial cells activated with inflammatory stimuli.

Boncela J, Przygodzka P, Papiewska-Pajak I, Wyroba E, Cierniewski CS.

J Biol Chem. 2011 Dec 16;286(50):43164-71. doi: 10.1074/jbc.M111.245647. Epub 2011 Oct 5.

2.

Plasminogen activator inhibitor type 1 interacts with alpha3 subunit of proteasome and modulates its activity.

Boncela J, Przygodzka P, Papiewska-Pajak I, Wyroba E, Osinska M, Cierniewski CS.

J Biol Chem. 2011 Feb 25;286(8):6820-31. doi: 10.1074/jbc.M110.173781. Epub 2010 Dec 6.

4.
5.

The role of proteasome beta subunits in gastrin-mediated transcription of plasminogen activator inhibitor-2 and regenerating protein1.

O'Hara A, Howarth A, Varro A, Dimaline R.

PLoS One. 2013;8(3):e59913. doi: 10.1371/journal.pone.0059913. Epub 2013 Mar 27.

6.

Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis.

Fish RJ, Kruithof EK.

Exp Cell Res. 2006 Feb 1;312(3):350-61. Epub 2005 Dec 5.

PMID:
16330024
7.
8.

Interaction of plasminogen activator inhibitor-2 and proteasome subunit, beta type 1.

Fan J, Zhang YQ, Li P, Hou M, Tan L, Wang X, Zhu YS.

Acta Biochim Biophys Sin (Shanghai). 2004 Jan;36(1):42-6.

9.

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.

van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ.

Blood. 1988 Nov;72(5):1467-73.

10.
11.
12.

Glucagon-like peptide-1 attenuates tumour necrosis factor-alpha-mediated induction of plasminogen [corrected] activator inhibitor-1 expression.

Liu H, Hu Y, Simpson RW, Dear AE.

J Endocrinol. 2008 Jan;196(1):57-65. doi: 10.1677/JOE-07-0387. Erratum in: J Endocrinol. 2010 Aug;206(2):248.

13.
14.

Localization and distribution of tissue type and urokinase type plasminogen activators and their inhibitors Type 1 and 2 in human and rhesus monkey fetal membranes.

Liu YX, Hu ZY, Liu K, Byrne S, Zou RJ, Ny T, d'Lacey C, Ockleford CD.

Placenta. 1998 Mar-Apr;19(2-3):171-80.

PMID:
9548184
16.

Successful silencing of plasminogen activator inhibitor-1 in human vascular endothelial cells using small interfering RNA.

Hecke A, Brooks H, Meryet-Figuière M, Minne S, Konstantinides S, Hasenfuss G, Lebleu B, Schäfer K.

Thromb Haemost. 2006 May;95(5):857-64.

PMID:
16676078
17.

Identification of interaction between PAI-2 and IRF-3.

Zhang YQ, Li P, Hou M, Wang X, Fan J, Tan L, Zhu YS.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Jul;35(7):661-5.

18.

Involvement of NADPH oxidase in oxidized LDL-induced upregulation of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells.

Zhao R, Ma X, Xie X, Shen GX.

Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E104-11. doi: 10.1152/ajpendo.91023.2008. Epub 2009 Apr 28.

19.

Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937.

Peiretti F, Fossat C, Anfosso F, Alessi MC, Henry M, Juhan-Vague I, Nalbone G.

Blood. 1996 Jan 1;87(1):162-73.

20.

Intracellular signaling pathways involved in inhibition of PAI-1 expression by CNP in endothelial cells.

Jerczynska H, Pawlowska Z.

Regul Pept. 2009 Jun 5;155(1-3):150-5. doi: 10.1016/j.regpep.2009.02.004. Epub 2009 Feb 13.

PMID:
19217919
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk